GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GDS 2021 | GLOBAL DRUG SURVEY GDS 2021. GDS2021: Why you should find 25 minutes this year to take part; GDS2021: Medical cannabis and dependence? Really.give us a break. Micro-dosing – how do

GLOBAL DRUG SURVEY

GDS2020 | www.globaldrugsurvey.com DATA COLLECTION PERIOD GDS2020 ran between Nov 7th– thDec 30 2019 (before the COVID pandemic) SAMPLE CHARACTERISTICS GLOBAL DRUG SURVEY 2020 (GDS2020) Data from over 110,000 people from > 25 countries were used in GDS SPECIAL EDITION ON COVID-19 gds special edition on covid-19 key findings report: executive summary prof.adam r. winstock, ms.ahnjili zhuparris, prof.gail gilchrist, dr.emma l. davies, dr.cheneal puljeviĆ, ms.laura potts, dr.larissa j. maier, assoc.prof.jason a. ferris & dr.monica j. barratt embargoed until 9am british summer time (bst), 9 september, 2020 the gds special edition on covid-19 was developed as part of a

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

DRUG PLEASURE RATINGS Drug Pleasure Ratings. The Net Pleasure Index is the first ever attempt to define and rank drugs in terms of the overall balance of pleasures and harms. It was developed with the specific aim of exploring the balance of positives and negatives for users of different drugs. The relationship between frequency of use and typical

dose used will

CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your

GLOBAL DRUG SURVEY

gds2019 | www.globaldrugsurvey.com global drug survey is an independent research organisation based in london, uk. we run the largest drug survey in the world LSD FIRST TIME USE : DRUG CHECKLIST LSD FIRST TIME USE : DRUG CHECKLIST This list has been particularly created for those trying LSD for the first time but is useful harm reduction advice for regular users too. GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GDS 2021 | GLOBAL DRUG SURVEY GDS 2021. GDS2021: Why you should find 25 minutes this year to take part; GDS2021: Medical cannabis and dependence? Really.give us a break. Micro-dosing – how do

GLOBAL DRUG SURVEY

GDS2020 | www.globaldrugsurvey.com DATA COLLECTION PERIOD GDS2020 ran between Nov 7th– thDec 30 2019 (before the COVID pandemic) SAMPLE CHARACTERISTICS GLOBAL DRUG SURVEY 2020 (GDS2020) Data from over 110,000 people from > 25 countries were used in GDS SPECIAL EDITION ON COVID-19 gds special edition on covid-19 key findings report: executive summary prof.adam r. winstock, ms.ahnjili zhuparris, prof.gail gilchrist, dr.emma l. davies, dr.cheneal puljeviĆ, ms.laura potts, dr.larissa j. maier, assoc.prof.jason a. ferris & dr.monica j. barratt embargoed until 9am british summer time (bst), 9 september, 2020 the gds special edition on covid-19 was developed as part of a

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

DRUG PLEASURE RATINGS Drug Pleasure Ratings. The Net Pleasure Index is the first ever attempt to define and rank drugs in terms of the overall balance of pleasures and harms. It was developed with the specific aim of exploring the balance of positives and negatives for users of different drugs. The relationship between frequency of use and typical

dose used will

CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your

GLOBAL DRUG SURVEY

gds2019 | www.globaldrugsurvey.com global drug survey is an independent research organisation based in london, uk. we run the largest drug survey in the world LSD FIRST TIME USE : DRUG CHECKLIST LSD FIRST TIME USE : DRUG CHECKLIST This list has been particularly created for those trying LSD for the first time but is useful harm reduction advice for regular users too. GDS COVID-19 SPECIAL EDITION: KEY FINDINGS REPORT GDS COVID-19 Special Edition: Key Findings Report. The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health

and relationships.

GDS SPECIAL EDITION ON COVID-19 gds special edition on covid-19 key findings report: executive summary prof.adam r. winstock, ms.ahnjili zhuparris, prof.gail gilchrist, dr.emma l. davies, dr.cheneal puljeviĆ, ms.laura potts, dr.larissa j. maier, assoc.prof.jason a. ferris & dr.monica j. barratt embargoed until 9am british summer time (bst), 9 september, 2020 the gds special edition on covid-19 was developed as part of a

GLOBAL DRUG SURVEY

GDS2020 | www.globaldrugsurvey.com DATA COLLECTION PERIOD GDS2020 ran between Nov 7th– thDec 30 2019 (before the COVID pandemic) SAMPLE CHARACTERISTICS GLOBAL DRUG SURVEY 2020 (GDS2020) Data from over 110,000 people from > 25 countries were used in

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

METHODS AND LIMITATIONS Global Drug Survey (GDS) runs the world’s biggest annual drug survey. Our last survey, GDS2016, ran for 6 weeks at the end of 2015, was translated into 10 languages and received over 100,000 responses from around the world. Over the last 3 years we have obtained data from over 300,000 people. By the end of 2016 we estimate our global

database

DATA ANALYSIS AND REPORT Data Analysis and Report. GDS offers a low cost approach to content rich data that can be used to explore diverse health outcomes associated with the use of drugs and alcohol within the general population. From helping us better understand the quantitative dynamics of personal decision-making, to helping inform novel interventions to detecting DRUG PLEASURE RATINGS Drug Pleasure Ratings. The Net Pleasure Index is the first ever attempt to define and rank drugs in terms of the overall balance of pleasures and harms. It was developed with the specific aim of exploring the balance of positives and negatives for users of different drugs. The relationship between frequency of use and typical

dose used will

THIS REPORT IS BASED ON DATA FROM > 40,000 PEOPLE WHO CLICK TO EDIT MASTER TITLE STYLE METHODS •Global Drug Survey (GDS) is the world’s largest annual drug survey. It uses an anonymous encrypted survey platform to recruit a large international, cross-sectional non-probability sample. THE GLOBAL DRUG SURVEY 2015 FINDINGS Participants from New Zealand, the Netherlands, and Hungary were the most experienced with cognitive enhancement (15.2% to 18.2%), while the rate of experienced U.S. participants was only slightly above the average (11.6%). Methylphenidate, illegal stimulants, and dexamphetamine were the substances most commonly used for enhancement.

GLOBAL DRUG SURVEY

Global Drug Survey

GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GLOBAL DRUG SURVEY

GDS2020 | www.globaldrugsurvey.com DATA COLLECTION PERIOD GDS2020 ran between Nov 7th– thDec 30 2019 (before the COVID pandemic) SAMPLE CHARACTERISTICS GLOBAL DRUG SURVEY 2020 (GDS2020) Data from over 110,000 people from > 25 countries were used in DRUG PLEASURE RATINGS Drug Pleasure Ratings. The Net Pleasure Index is the first ever attempt to define and rank drugs in terms of the overall balance of pleasures and harms. It was developed with the specific aim of exploring the balance of positives and negatives for users of different drugs. The relationship between frequency of use and typical

dose used will

GDS 2019 | GLOBAL DRUG SURVEY GDS 2019 Dear partners and friends of GDS GDS2019 launch blogs. Please find to the left a selection of launch pieces that you may wish to share, translate, edit, copy or otherwise use in your promotion of

GDS2019 this year.

DRUG EDUCATION VIDEOS Drug Education Videos. The style is conversational / show and tell, with John and Adam handling real drugs in a laboratory setting as we they talk about various aspects of them, from purity, routes of use, to acute harms, sought after effects, harm reduction and main treatment options. The training videos can be provided complete with

teaching

GLOBAL DRUG SURVEY

gds2019 | www.globaldrugsurvey.com global drug survey is an independent research organisation based in london, uk. we run the largest drug survey in the world CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your THINKING OF USING LSD FOR THE FIRST TIME? HERE ARE SOME Thinking of using LSD for the first time? Here are some things to think about. A person’s first drug experience can be particularly risky. The risks are likely to be higher if you are on your own, take the wrong dose, are in the wrong place or time, or are already under the influence of something else – usually and probably most dangerously, alcohol. THE GLOBAL DRUG SURVEY 2015 FINDINGS Participants from New Zealand, the Netherlands, and Hungary were the most experienced with cognitive enhancement (15.2% to 18.2%), while the rate of experienced U.S. participants was only slightly above the average (11.6%). Methylphenidate, illegal stimulants, and dexamphetamine were the substances most commonly used for enhancement. GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GLOBAL DRUG SURVEY

GDS2020 | www.globaldrugsurvey.com DATA COLLECTION PERIOD GDS2020 ran between Nov 7th– thDec 30 2019 (before the COVID pandemic) SAMPLE CHARACTERISTICS GLOBAL DRUG SURVEY 2020 (GDS2020) Data from over 110,000 people from > 25 countries were used in DRUG PLEASURE RATINGS Drug Pleasure Ratings. The Net Pleasure Index is the first ever attempt to define and rank drugs in terms of the overall balance of pleasures and harms. It was developed with the specific aim of exploring the balance of positives and negatives for users of different drugs. The relationship between frequency of use and typical

dose used will

GDS 2019 | GLOBAL DRUG SURVEY GDS 2019 Dear partners and friends of GDS GDS2019 launch blogs. Please find to the left a selection of launch pieces that you may wish to share, translate, edit, copy or otherwise use in your promotion of

GDS2019 this year.

DRUG EDUCATION VIDEOS Drug Education Videos. The style is conversational / show and tell, with John and Adam handling real drugs in a laboratory setting as we they talk about various aspects of them, from purity, routes of use, to acute harms, sought after effects, harm reduction and main treatment options. The training videos can be provided complete with

teaching

GLOBAL DRUG SURVEY

gds2019 | www.globaldrugsurvey.com global drug survey is an independent research organisation based in london, uk. we run the largest drug survey in the world CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your THINKING OF USING LSD FOR THE FIRST TIME? HERE ARE SOME Thinking of using LSD for the first time? Here are some things to think about. A person’s first drug experience can be particularly risky. The risks are likely to be higher if you are on your own, take the wrong dose, are in the wrong place or time, or are already under the influence of something else – usually and probably most dangerously, alcohol. THE GLOBAL DRUG SURVEY 2015 FINDINGS Participants from New Zealand, the Netherlands, and Hungary were the most experienced with cognitive enhancement (15.2% to 18.2%), while the rate of experienced U.S. participants was only slightly above the average (11.6%). Methylphenidate, illegal stimulants, and dexamphetamine were the substances most commonly used for enhancement. GDS COVID-19 COUNTRY REPORTS The username for access is guest@globaldrugsurvey.com whilst the password 5R69t3zMFytcHUJ. Did you find our specific Country Reports interesting? If so, please donate. By accessing interactive country reports GDS has allowed you to you see key findings from different countries. We would appreciate any form of donation to support GDS,

you can do

GDS SPECIAL EDITION ON COVID-19 gds special edition on covid-19 key findings report: executive summary prof.adam r. winstock, ms.ahnjili zhuparris, prof.gail gilchrist, dr.emma l. davies, dr.cheneal puljeviĆ, ms.laura potts, dr.larissa j. maier, assoc.prof.jason a. ferris & dr.monica j. barratt embargoed until 9am british summer time (bst), 9 september, 2020 the gds special edition on covid-19 was developed as part of a METHODS AND LIMITATIONS Global Drug Survey (GDS) runs the world’s biggest annual drug survey. Our last survey, GDS2016, ran for 6 weeks at the end of 2015, was translated into 10 languages and received over 100,000 responses from around the world. Over the last 3 years we have obtained data from over 300,000 people. By the end of 2016 we estimate our global

database

GDS COVID-19 SPECIAL EDITION: KEY FINDINGS REPORT GDS COVID-19 Special Edition: Key Findings Report. The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health

and relationships.

DRUG EDUCATION VIDEOS Drug Education Videos. The style is conversational / show and tell, with John and Adam handling real drugs in a laboratory setting as we they talk about various aspects of them, from purity, routes of use, to acute harms, sought after effects, harm reduction and main treatment options. The training videos can be provided complete with

teaching

DRUGS METER

Drugs Meter. Drugs Meter allows users to see how their drug use compares to other people just like them, offering objective, personalised feedback that takes their personal features in to account. With an overview of total drug use and in depth analysis for nine drugs at present, drugs meter gives objective feedback informed

by medical experts.

DATA ANALYSIS AND REPORT Data Analysis and Report. GDS offers a low cost approach to content rich data that can be used to explore diverse health outcomes associated with the use of drugs and alcohol within the general population. From helping us better understand the quantitative dynamics of personal decision-making, to helping inform novel interventions to detecting

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

THIS REPORT IS BASED ON DATA FROM > 40,000 PEOPLE WHO CLICK TO EDIT MASTER TITLE STYLE METHODS •Global Drug Survey (GDS) is the world’s largest annual drug survey. It uses an anonymous encrypted survey platform to recruit a large international, cross-sectional non-probability sample.

GLOBAL DRUG SURVEY

Global Drug Survey

GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GLOBAL DRUG SURVEY

GDS2020 | www.globaldrugsurvey.com DATA COLLECTION PERIOD GDS2020 ran between Nov 7th– thDec 30 2019 (before the COVID pandemic) SAMPLE CHARACTERISTICS GLOBAL DRUG SURVEY 2020 (GDS2020) Data from over 110,000 people from > 25 countries were used in GDS 2019 | GLOBAL DRUG SURVEY GDS 2019 Dear partners and friends of GDS GDS2019 launch blogs. Please find to the left a selection of launch pieces that you may wish to share, translate, edit, copy or otherwise use in your promotion of

GDS2019 this year.

DRUG PLEASURE RATINGS Drug Pleasure Ratings. The Net Pleasure Index is the first ever attempt to define and rank drugs in terms of the overall balance of pleasures and harms. It was developed with the specific aim of exploring the balance of positives and negatives for users of different drugs. The relationship between frequency of use and typical

dose used will

DRUG EDUCATION VIDEOS Drug Education Videos. The style is conversational / show and tell, with John and Adam handling real drugs in a laboratory setting as we they talk about various aspects of them, from purity, routes of use, to acute harms, sought after effects, harm reduction and main treatment options. The training videos can be provided complete with

teaching

CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your

GLOBAL DRUG SURVEY

gds2019 | www.globaldrugsurvey.com global drug survey is an independent research organisation based in london, uk. we run the largest drug survey in the world THE GLOBAL DRUG SURVEY 2015 FINDINGS Participants from New Zealand, the Netherlands, and Hungary were the most experienced with cognitive enhancement (15.2% to 18.2%), while the rate of experienced U.S. participants was only slightly above the average (11.6%). Methylphenidate, illegal stimulants, and dexamphetamine were the substances most commonly used for enhancement. THINKING OF USING LSD FOR THE FIRST TIME? HERE ARE SOME Thinking of using LSD for the first time? Here are some things to think about. A person’s first drug experience can be particularly risky. The risks are likely to be higher if you are on your own, take the wrong dose, are in the wrong place or time, or are already under the influence of something else – usually and probably most dangerously, alcohol. GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GLOBAL DRUG SURVEY

GDS2020 | www.globaldrugsurvey.com DATA COLLECTION PERIOD GDS2020 ran between Nov 7th– thDec 30 2019 (before the COVID pandemic) SAMPLE CHARACTERISTICS GLOBAL DRUG SURVEY 2020 (GDS2020) Data from over 110,000 people from > 25 countries were used in GDS 2019 | GLOBAL DRUG SURVEY GDS 2019 Dear partners and friends of GDS GDS2019 launch blogs. Please find to the left a selection of launch pieces that you may wish to share, translate, edit, copy or otherwise use in your promotion of

GDS2019 this year.

DRUG PLEASURE RATINGS Drug Pleasure Ratings. The Net Pleasure Index is the first ever attempt to define and rank drugs in terms of the overall balance of pleasures and harms. It was developed with the specific aim of exploring the balance of positives and negatives for users of different drugs. The relationship between frequency of use and typical

dose used will

DRUG EDUCATION VIDEOS Drug Education Videos. The style is conversational / show and tell, with John and Adam handling real drugs in a laboratory setting as we they talk about various aspects of them, from purity, routes of use, to acute harms, sought after effects, harm reduction and main treatment options. The training videos can be provided complete with

teaching

CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your

GLOBAL DRUG SURVEY

gds2019 | www.globaldrugsurvey.com global drug survey is an independent research organisation based in london, uk. we run the largest drug survey in the world THE GLOBAL DRUG SURVEY 2015 FINDINGS Participants from New Zealand, the Netherlands, and Hungary were the most experienced with cognitive enhancement (15.2% to 18.2%), while the rate of experienced U.S. participants was only slightly above the average (11.6%). Methylphenidate, illegal stimulants, and dexamphetamine were the substances most commonly used for enhancement. THINKING OF USING LSD FOR THE FIRST TIME? HERE ARE SOME Thinking of using LSD for the first time? Here are some things to think about. A person’s first drug experience can be particularly risky. The risks are likely to be higher if you are on your own, take the wrong dose, are in the wrong place or time, or are already under the influence of something else – usually and probably most dangerously, alcohol. GDS COVID-19 COUNTRY REPORTS The username for access is guest@globaldrugsurvey.com whilst the password 5R69t3zMFytcHUJ. Did you find our specific Country Reports interesting? If so, please donate. By accessing interactive country reports GDS has allowed you to you see key findings from different countries. We would appreciate any form of donation to support GDS,

you can do

GDS COVID-19 SPECIAL EDITION: KEY FINDINGS REPORT GDS COVID-19 Special Edition: Key Findings Report. The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health

and relationships.

GDS 2019 | GLOBAL DRUG SURVEY GDS 2019 Dear partners and friends of GDS GDS2019 launch blogs. Please find to the left a selection of launch pieces that you may wish to share, translate, edit, copy or otherwise use in your promotion of

GDS2019 this year.

METHODS AND LIMITATIONS Global Drug Survey (GDS) runs the world’s biggest annual drug survey. Our last survey, GDS2016, ran for 6 weeks at the end of 2015, was translated into 10 languages and received over 100,000 responses from around the world. Over the last 3 years we have obtained data from over 300,000 people. By the end of 2016 we estimate our global

database

GLOBAL DRUG SURVEY

gds2019 | www.globaldrugsurvey.com global drug survey is an independent research organisation based in london, uk. we run the largest drug survey in the world DRUG EDUCATION VIDEOS Drug Education Videos. The style is conversational / show and tell, with John and Adam handling real drugs in a laboratory setting as we they talk about various aspects of them, from purity, routes of use, to acute harms, sought after effects, harm reduction and main treatment options. The training videos can be provided complete with

teaching

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

DATA ANALYSIS AND REPORT Data Analysis and Report. GDS offers a low cost approach to content rich data that can be used to explore diverse health outcomes associated with the use of drugs and alcohol within the general population. From helping us better understand the quantitative dynamics of personal decision-making, to helping inform novel interventions to detecting THIS REPORT IS BASED ON DATA FROM > 40,000 PEOPLE WHO CLICK TO EDIT MASTER TITLE STYLE METHODS •Global Drug Survey (GDS) is the world’s largest annual drug survey. It uses an anonymous encrypted survey platform to recruit a large international, cross-sectional non-probability sample.

GLOBAL DRUG SURVEY

Global Drug Survey

GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GDS COVID-19 COUNTRY REPORTS The username for access is guest@globaldrugsurvey.com whilst the password 5R69t3zMFytcHUJ. Did you find our specific Country Reports interesting? If so, please donate. By accessing interactive country reports GDS has allowed you to you see key findings from different countries. We would appreciate any form of donation to support GDS,

you can do

GDS COVID-19 SPECIAL EDITION: KEY FINDINGS REPORT GDS COVID-19 Special Edition: Key Findings Report. The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health

and relationships.

GDS 2019 | GLOBAL DRUG SURVEY GDS 2019 Dear partners and friends of GDS GDS2019 launch blogs. Please find to the left a selection of launch pieces that you may wish to share, translate, edit, copy or otherwise use in your promotion of

GDS2019 this year.

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your THINKING OF USING LSD FOR THE FIRST TIME? HERE ARE SOME Thinking of using LSD for the first time? Here are some things to think about. A person’s first drug experience can be particularly risky. The risks are likely to be higher if you are on your own, take the wrong dose, are in the wrong place or time, or are already under the influence of something else – usually and probably most dangerously, alcohol. LSD FIRST TIME USE : DRUG CHECKLIST LSD FIRST TIME USE : DRUG CHECKLIST This list has been particularly created for those trying LSD for the first time but is useful harm reduction advice for regular users too.

GLOBAL DRUG SURVEY

Global Drug Survey

GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GDS COVID-19 COUNTRY REPORTS The username for access is guest@globaldrugsurvey.com whilst the password 5R69t3zMFytcHUJ. Did you find our specific Country Reports interesting? If so, please donate. By accessing interactive country reports GDS has allowed you to you see key findings from different countries. We would appreciate any form of donation to support GDS,

you can do

GDS COVID-19 SPECIAL EDITION: KEY FINDINGS REPORT GDS COVID-19 Special Edition: Key Findings Report. The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health

and relationships.

GDS 2019 | GLOBAL DRUG SURVEY GDS 2019 Dear partners and friends of GDS GDS2019 launch blogs. Please find to the left a selection of launch pieces that you may wish to share, translate, edit, copy or otherwise use in your promotion of

GDS2019 this year.

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your THINKING OF USING LSD FOR THE FIRST TIME? HERE ARE SOME Thinking of using LSD for the first time? Here are some things to think about. A person’s first drug experience can be particularly risky. The risks are likely to be higher if you are on your own, take the wrong dose, are in the wrong place or time, or are already under the influence of something else – usually and probably most dangerously, alcohol. LSD FIRST TIME USE : DRUG CHECKLIST LSD FIRST TIME USE : DRUG CHECKLIST This list has been particularly created for those trying LSD for the first time but is useful harm reduction advice for regular users too.

GLOBAL DRUG SURVEY

Global Drug Survey

GDS COVID-19 SPECIAL EDITION: KEY FINDINGS REPORT GDS COVID-19 Special Edition: Key Findings Report. The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health

and relationships.

PAST FINDINGS

Past Findings. Global Drug Survey aims to be transparent about our data, most of which we publish online here alongside our academic

articles.

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

METHODS AND LIMITATIONS Global Drug Survey (GDS) runs the world’s biggest annual drug survey. Our last survey, GDS2016, ran for 6 weeks at the end of 2015, was translated into 10 languages and received over 100,000 responses from around the world. Over the last 3 years we have obtained data from over 300,000 people. By the end of 2016 we estimate our global

database

DRUGS METER

Drugs Meter. Drugs Meter allows users to see how their drug use compares to other people just like them, offering objective, personalised feedback that takes their personal features in to account. With an overview of total drug use and in depth analysis for nine drugs at present, drugs meter gives objective feedback informed

by medical experts.

DATA ANALYSIS AND REPORT Data Analysis and Report. GDS offers a low cost approach to content rich data that can be used to explore diverse health outcomes associated with the use of drugs and alcohol within the general population. From helping us better understand the quantitative dynamics of personal decision-making, to helping inform novel interventions to detecting DRUG PLEASURE RATINGS Drug Pleasure Ratings. The Net Pleasure Index is the first ever attempt to define and rank drugs in terms of the overall balance of pleasures and harms. It was developed with the specific aim of exploring the balance of positives and negatives for users of different drugs. The relationship between frequency of use and typical

dose used will

THE HIGHWAY CODE

Based on the experience of almost 80,000 people who took part in the Global Drug Survey 2014, the High-way Code is the first guide to safer drug use voted for by people who take drugs. The results seem to suggest that safer drug use can be more enjoyable drug use. THIS REPORT IS BASED ON DATA FROM > 40,000 PEOPLE WHO CLICK TO EDIT MASTER TITLE STYLE METHODS •Global Drug Survey (GDS) is the world’s largest annual drug survey. It uses an anonymous encrypted survey platform to recruit a large international, cross-sectional non-probability sample. THE GLOBAL DRUG SURVEY 2015 FINDINGS Participants from New Zealand, the Netherlands, and Hungary were the most experienced with cognitive enhancement (15.2% to 18.2%), while the rate of experienced U.S. participants was only slightly above the average (11.6%). Methylphenidate, illegal stimulants, and dexamphetamine were the substances most commonly used for enhancement. GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GDS COVID-19 COUNTRY REPORTS The username for access is guest@globaldrugsurvey.com whilst the password 5R69t3zMFytcHUJ. Did you find our specific Country Reports interesting? If so, please donate. By accessing interactive country reports GDS has allowed you to you see key findings from different countries. We would appreciate any form of donation to support GDS,

you can do

GDS COVID-19 SPECIAL EDITION: KEY FINDINGS REPORT GDS COVID-19 Special Edition: Key Findings Report. The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health

and relationships.

GDS 2019 | GLOBAL DRUG SURVEY GDS 2019 Dear partners and friends of GDS GDS2019 launch blogs. Please find to the left a selection of launch pieces that you may wish to share, translate, edit, copy or otherwise use in your promotion of

GDS2019 this year.

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your THINKING OF USING LSD FOR THE FIRST TIME? HERE ARE SOME Thinking of using LSD for the first time? Here are some things to think about. A person’s first drug experience can be particularly risky. The risks are likely to be higher if you are on your own, take the wrong dose, are in the wrong place or time, or are already under the influence of something else – usually and probably most dangerously, alcohol. LSD FIRST TIME USE : DRUG CHECKLIST LSD FIRST TIME USE : DRUG CHECKLIST This list has been particularly created for those trying LSD for the first time but is useful harm reduction advice for regular users too.

GLOBAL DRUG SURVEY

Global Drug Survey

GLOBAL DRUG SURVEYGDS COVID-19 KEY FINDINGSGDS SURVEYSPAST FINDINGSPRODUCTS AND SERVICES GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools GDS 2020 | GLOBAL DRUG SURVEY Global Drug Survey (GDS) runs the world’s largest survey. Over the last 8 years more than 750,000 people have taken part in our annual, anonymous confidential survey. GDS2020 will be translated into 16 languages, with partners in over 30 countries. GDS believes that the expertise and experience of people who use alcohol and other drugs can

be

GDS COVID-19 COUNTRY REPORTS The username for access is guest@globaldrugsurvey.com whilst the password 5R69t3zMFytcHUJ. Did you find our specific Country Reports interesting? If so, please donate. By accessing interactive country reports GDS has allowed you to you see key findings from different countries. We would appreciate any form of donation to support GDS,

you can do

GDS COVID-19 SPECIAL EDITION: KEY FINDINGS REPORT GDS COVID-19 Special Edition: Key Findings Report. The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health

and relationships.

GDS 2019 | GLOBAL DRUG SURVEY GDS 2019 Dear partners and friends of GDS GDS2019 launch blogs. Please find to the left a selection of launch pieces that you may wish to share, translate, edit, copy or otherwise use in your promotion of

GDS2019 this year.

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

CANNABIS: HOW TO CUT DOWN OR STOP USING How to cut down. Less cannabis per joint/pipe/bowl – make your weed go further. Delay the time of your first smoke of the day. Increase time between joints (or equivalent). Avoiding smoking spiffs back to back and leaving gaps between smokes, mean you lower your THINKING OF USING LSD FOR THE FIRST TIME? HERE ARE SOME Thinking of using LSD for the first time? Here are some things to think about. A person’s first drug experience can be particularly risky. The risks are likely to be higher if you are on your own, take the wrong dose, are in the wrong place or time, or are already under the influence of something else – usually and probably most dangerously, alcohol. LSD FIRST TIME USE : DRUG CHECKLIST LSD FIRST TIME USE : DRUG CHECKLIST This list has been particularly created for those trying LSD for the first time but is useful harm reduction advice for regular users too.

GLOBAL DRUG SURVEY

Global Drug Survey

GDS COVID-19 SPECIAL EDITION: KEY FINDINGS REPORT GDS COVID-19 Special Edition: Key Findings Report. The GDS Special Edition on COVID-19 was developed as part of a global effort to better understand the impact of the pandemic on people’s lives with a specific focus on the use of alcohol and other drugs, mental health

and relationships.

PAST FINDINGS

Past Findings. Global Drug Survey aims to be transparent about our data, most of which we publish online here alongside our academic

articles.

CORE RESEARCH TEAM

Dr. Jason Ferris PhD. Jason is the chief biostatistician for the Global Drug Survey. He is a Senior Research Fellow at the Institute for Social Science Research, University of Queensland and holds an NHMRC Postdoctoral Fellowship. He leads the Drug Alcohol and Crime Research Program and works on the Research Methods and Social

Statistics Program.

METHODS AND LIMITATIONS Global Drug Survey (GDS) runs the world’s biggest annual drug survey. Our last survey, GDS2016, ran for 6 weeks at the end of 2015, was translated into 10 languages and received over 100,000 responses from around the world. Over the last 3 years we have obtained data from over 300,000 people. By the end of 2016 we estimate our global

database

DRUGS METER

Drugs Meter. Drugs Meter allows users to see how their drug use compares to other people just like them, offering objective, personalised feedback that takes their personal features in to account. With an overview of total drug use and in depth analysis for nine drugs at present, drugs meter gives objective feedback informed

by medical experts.

DATA ANALYSIS AND REPORT Data Analysis and Report. GDS offers a low cost approach to content rich data that can be used to explore diverse health outcomes associated with the use of drugs and alcohol within the general population. From helping us better understand the quantitative dynamics of personal decision-making, to helping inform novel interventions to detecting DRUG PLEASURE RATINGS Drug Pleasure Ratings. The Net Pleasure Index is the first ever attempt to define and rank drugs in terms of the overall balance of pleasures and harms. It was developed with the specific aim of exploring the balance of positives and negatives for users of different drugs. The relationship between frequency of use and typical

dose used will

THE HIGHWAY CODE

Based on the experience of almost 80,000 people who took part in the Global Drug Survey 2014, the High-way Code is the first guide to safer drug use voted for by people who take drugs. The results seem to suggest that safer drug use can be more enjoyable drug use. THIS REPORT IS BASED ON DATA FROM > 40,000 PEOPLE WHO CLICK TO EDIT MASTER TITLE STYLE METHODS •Global Drug Survey (GDS) is the world’s largest annual drug survey. It uses an anonymous encrypted survey platform to recruit a large international, cross-sectional non-probability sample. THE GLOBAL DRUG SURVEY 2015 FINDINGS Participants from New Zealand, the Netherlands, and Hungary were the most experienced with cognitive enhancement (15.2% to 18.2%), while the rate of experienced U.S. participants was only slightly above the average (11.6%). Methylphenidate, illegal stimulants, and dexamphetamine were the substances most commonly used for enhancement.

GLOBAL DRUG SURVEY

Search Search

Menu

* GDS 2020

* GDS 2020 Psychedelics Report * GDS 2020 Key Findings * GDS COVID-19 Key Findings

* GDS Surveys

* Why Global Drug Survey is running a UK cannabis survey? * GDS Sample and characteristics * Survey composition * Ethics, Sharing & Security

* Past Findings

* GDS 2019

* GDS 2018

* GDS 2017

* GDS 2015

* GDS 2014

* YouTube videos of Global Drug Survey Findings

* Academic Articles

* Products and services * Participant Recruitment and Survey Design * Data Analysis and Report

* Data insight

* Digital Health Apps * Consultancy and Training * Drug Education Videos * Expert witness and Legal Opinion * Free online resources

* Drinks Meter

* Drugs Meter

* Drugs Meter Mini

* Safer Use Limits

* One Too Many

* The Highway Code

* About GDS

* In the media

* Clients and partners

* Blog

* Testimonials

* Contact

GDS: THE WORLD’S LARGEST DRUG SURVEY The GDS 2020 Psychedelics Report

Download Report

The GDS 2020 Executive Summary View Executive Summary GDS 2020: WHY YOU SHOULD FIND 25 MINUTES THIS YEAR TO TAKE PART

Read more

GDS 2021: MEDICAL CANNABIS AND DEPENDENCE? REALLY... GIVE US A BREAK.

Read more

MICRO-DOSING – HOW DO YOU DO IT, AND WHAT ARE YOUR EXPERIENCES?

Read more

SHARING SPLIFFS, SNORTERS AND DRUGS – HOW MUCH OF DIFFERENCE HAS

COVID MADE?

Read more

PARTYING LIKE IT’S 2021. HOW CLUBS AND PUBS NEED TO ADAPT IN 2021

– HAVE YOUR SAY!

Read more

DIGITAL PLEASURES: ASMR, BINAURAL BEATS AND OTHER WAYS TO CHANGE YOUR

BRAIN WITHOUT DRUGS

Read more

ACCESSING SUPPORT FOR MENTAL HEALTH, ALCOHOL AND OTHER DRUG PROBLEMS

DURING COVID

Read more

GDS: THE WORLD’S LARGEST DRUG SURVEY

SOCIAL UPDATES

2 June 2021

RT @I_am_emma: And here’s @JasonFerris22 presenting on our @GlobalDrugSurvy data and shouting out @davidfoxcroft ‘s snazzy

analysis and ope…

Open

21 May 2021

MDMA Therapy for PTSD Could Be Legal by 2023. A DIY Culture is Already Thriving. “The longer the delay in rolling o… https://t.co/WyldayCzAp

Open

Our media partners help spread the word worldwide these include... See our full list of media partners

WHY USE GDS?

GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country. GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools, designed and analysed by leading experts in the fields of epidemiology, addiction, criminology, toxicology and sociology GDS has access to drug use data from over 500,000 people from over 50 countries. The GDS sampling frame allows you to effectively compare population segments - young, old, males, females, gay, straight, clubbers, thin people, obese people, vegetarians, those with a current psychiatric symptoms and diagnoses, students, northerners, southerners. GDS helps you better understand the quantitative dynamics of personal decision-making about drug use, detects regional differences in patterns of drug use and related harm, and informs novel

interventions.

GDS creates beautiful data reports, digital health assessment tools and free harm reduction resources that aim to make drug use safer regardless of the legal status of the drug GDS reaches hidden, sentinel and hard to reach populations and puts you on top of emerging drug trends in your country and major cities. LEARN MORE ABOUT GDS Download our PDF brochure

Online resource

DRINKS METER

The best drinking app and screening tool in the world – use in your region / service now.

Learn more

If you value our research, we would greatly appreciate your

contribution

Please help us continue in our work.

DONATE TO GDS HERE

GLOBAL DRUG SURVEY

* GDS 2021

* About us

* GDS Surveys

* Past Findings

* Products and services * Free online resources

* In the media

* Clients and partners

* Blog

* Testimonials

* Privacy policy

* Contact

CONNECT

* Twitter

* Facebook

* YouTube

* RSS

POPULAR ARTICLES

* Dark-net markets: the good, the bad and ugly? * Legislating for honest conversations – zero tolerance meets

maximum education

* From medicine to magic. Just how good is marijuana as a medicine * Cannabis law reform – what do cannabis users want? * Busted! How police detect and deal with personal drug possession

around the world.

* Understanding and Working with Difficult Psychedelic Experiences Copyright © 2021 Global Drug Survey. All rights reserved. |

Studiomade